Italy
CDP Venture Capital
Italy's national venture platform. €260M joint programme with EIF to accelerate tech transfer from Italian research institutions.
Fund size€260M
BackingEIF
Loading page...
Log inCreate account
Loading page...
Find the funds that fit what you’re building. European venture capital, organised by stage, sector and geography.
Find investors ↓Start with stage and geography. Open a profile to check the fund’s thesis before you reach out.
Fund size is the whole fund, not the cheque you can raise. EIF backing does not mean a fund is currently accepting pitches. Unknown stages stay in “All funds”.
Italy's national venture platform. €260M joint programme with EIF to accelerate tech transfer from Italian research institutions.
Maia Ventures is a Milan-based seed-stage fund investing in early-stage agrifood and food technology startups across Italy and Europe. Its EUR 55M debut fund (Fund I) writes initial tickets of roughly EUR 500k to EUR 1.5M into 20 to 25 companies and is backed by the European Investment Fund and CDP Venture Capital. The fund is classified SFDR Article 8 and targets healthier ingredients, food waste reduction and supply chain innovation.
Primo Ventures is a seed and Series A fund based in Milan, Italy, with around EUR 100M in its Fund III vehicle. It backs early-stage Italian startups, mainly in software, fintech and SaaS, and is backed by the EIF. Typical tickets run from roughly EUR 1M to EUR 5M.
21 Invest Healthcare is a growth and expansion-stage fund focused on the healthcare and life-science sector, managed by a regulated Italian asset manager (SGR) and part of the 21 Invest (formerly 21 Investimenti) group in Italy. It invests in established healthcare companies to support their growth and expansion.
FSI Mid-Market Growth Equity Fund is a growth equity fund managed by FSI SGR S.p.A. in Italy. It invests in mid-market Italian companies looking to expand internationally, typically taking minority stakes alongside founding families and without using leverage. FSI is the largest private equity manager in Europe dedicated to a single country.
Innogest Capital is an early-stage venture fund managed by Innogest SGR, based in Italy with offices in Turin and Milan. Founded in 2006, the firm backs seed and early-stage companies in digital and medtech, managing around EUR 200 million across its funds.
Primo Health is a life-science fund managed by Primo Ventures SGR in Italy. It invests in growth and expansion-stage health and life-science companies, mainly in the Italian market.
Programma 101 is an early-stage technology fund managed by P101 SGR, based in Milan. P101 was founded in 2013 by Andrea Di Camillo and invests in digital and tech-driven startups across Italy and Europe, focusing on areas such as fintech, proptech and software, with the firm managing roughly EUR 500M across its fund series.
Sofinnova Telethon SCA-RAIF is an Italy-focused life sciences fund managed by Sofinnova Partners SAS. Launched in 2018 with the Telethon Foundation and totalling about EUR 108M, it makes early-stage investments in Italian biotech companies developing treatments for rare and genetic diseases. Portfolio companies include AAVantgarde Bio, Genespire and Alia Therapeutics.
UV T-Growth is a growth-stage technology fund managed by United Ventures SGR in Italy. It is United Ventures' first late-stage fund, with a target around EUR 150-180M, and backs scale-up companies in areas such as AI, cybersecurity, cloud, fintech and SaaS. CDP Venture Capital is among its investors.
The XGen Venture Life Science Fund is a life sciences and health fund managed by XGen Venture SGR, based in Italy. It invests in early-stage Italian life science and healthcare companies, including biotech, medtech and digital health.
A reviewed startup profile, a website backlink and a place for investors and consortium partners to discover your work.
Connect with your free EUACC account.
